Bracciamà Valeria, Vaisitti Tiziana, Mioli Fiorenza, Faini Angelo Corso, Del Prever Giulia Margherita Brach, Martins Vitor Hugo, Camilla Roberta, Mattozzi Francesca, Pieretti Silvia, Luca Maria, Romeo Carmelo Maria, Saglia Claudia, Migliorero Martina, Arruga Francesca, Carli Diana, Amoroso Antonio, Lonardi Pietro, Deaglio Silvia, Peruzzi Licia
Immunogenetics and Transplant Biology, AOU Città della Salute e della Scienza, ERKNet Center & Department of Medical Sciences, University of Turin, Turin, Italy.
Nephrology Dialysis and Transplantation, ERKNet Center, Regina Margherita Children's Hospital, Turin, Italy.
Pediatr Nephrol. 2025 Mar;40(3):743-753. doi: 10.1007/s00467-024-06548-6. Epub 2024 Oct 10.
Cystic kidney disease is a heterogeneous group of hereditary and non-hereditary pathologic conditions, associated with the development of renal cysts. These conditions may be present both in children and adults. Cysts can even be observed already during the prenatal age, and pediatric patients with cysts need to be clinically monitored. An early clinical and genetic diagnosis is therefore mandatory for optimal patient management. The aim of this study was to perform genetic analyses in patients with echographic evidence of kidney cysts to provide an early molecular diagnosis.
A cohort of 70 pediatric patients was enrolled and clinically studied at the time of first recruitment and at follow-up. Genetic testing by clinical exome sequencing was performed and a panel of genes responsible for "cystic kidneys" was analyzed to identify causative variants. Sanger validation and segregation studies were exploited for the final classification of the variants and accurate genetic counseling.
Data showed that 53/70 of pediatric patients referred with a clinical suspicion of cystic kidney disease presented a causative genetic variant. In a significant proportion of the cohort (24/70), evidence of hyper-echogenic/cystic kidneys was already present in the prenatal period, even in the absence of a positive family history.
This study suggests that cystic kidney disease may develop since the very early stages of life and that screening programs based on ultrasound scans and genetic testing play a critical role in diagnosis, allowing for better clinical management and tailored genetic counseling to the family.
囊性肾病是一组遗传性和非遗传性病理状况的异质性疾病,与肾囊肿的形成有关。这些疾病在儿童和成人中均可出现。囊肿甚至在产前就可被观察到,患有囊肿的儿科患者需要进行临床监测。因此,为了实现最佳的患者管理,早期临床和基因诊断是必不可少的。本研究的目的是对有肾囊肿超声证据的患者进行基因分析,以提供早期分子诊断。
招募了一组70名儿科患者,并在首次招募时和随访时进行临床研究。通过临床外显子组测序进行基因检测,并分析一组与“囊性肾病”相关的基因,以确定致病变异。利用桑格验证和分离研究对变异进行最终分类,并提供准确的遗传咨询。
数据显示,70名临床怀疑患有囊性肾病的儿科患者中,有53名存在致病基因变异。在相当一部分队列(24/70)中,即使没有阳性家族史,在产前就已出现高回声/囊性肾的证据。
本研究表明,囊性肾病可能在生命的早期阶段就已发生,基于超声扫描和基因检测的筛查计划在诊断中起着关键作用,有助于更好地进行临床管理,并为家庭提供量身定制的遗传咨询。